Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHF 5188 (Budesonide/Carmoterol) in Asthma
NCT01070524Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jan 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of carmoterol in asthma (3 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Trough Forced Expiratory Volume in 1 Second at 28 days. Started Jan 2010; status: completed.
02
Drugs
carmoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01070524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070524.